Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys
Open accessAbstract
There is anatomical and functional evidence that ventral midbrain dopaminergic (DA) cell groups and the subthalamic nucleus (STN) receive noradrenergic innervation in rodents, but much less is known about these interactions in primates. Degeneration of NE neurons in the locus coeruleus (LC) and related brainstem NE cell groups is a well-established pathological feature of Parkinson's disease (PD), but the development of such pathology in animal models of PD has been inconsistent across species and laboratories. We recently demonstrated 30-40% neuronal loss in the LC, A5 and A6 NE cell groups of rhesus monkeys rendered parkinsonian by chronic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). In this study, we used dopamine-beta-hydroxylase (DβH) immunocytochemistry to assess the impact of this neuronal loss on the number of NE terminal-like varicosities in the substantia nigra pars compacta (SNC), ventral tegmental area (VTA), retrorubral field (RRF) and STN of MPTP-treated parkinsonian monkeys. Our findings reveal that the NE innervation of the ventral midbrain and STN of normal monkeys is heterogeneously distributed being far more extensive in the VTA, RRF and dorsal tier of the SNC than in the ventral SNC and STN. In parkinsonian monkeys, all regions underwent a significant (~50-70%) decrease in NE innervation. At the electron microscopic level, some DβH-positive terminals formed asymmetric axo-dendritic synapses in VTA and STN. These findings demonstrate that the VTA, RRF and SNCd are the main ventral midbrain targets of ascending NE inputs, and that these connections undergo a major break-down in chronically MPTP-treated parkinsonian monkeys. This severe degeneration of the ascending NE system may contribute to the pathophysiology of ventral midbrain and STN neurons in PD.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Light hair color and red hair MC1R alleles are risk factors for both melanoma and Parkinson's disease, and Parkinson's disease patients have a 7-fold elevated melanoma risk.
“Light hair color and the red hair alleles of the MC1R gene are risk factors for both melanoma and PD, while PD patients have a 7-fold elevated risk for melanoma (239, 240);”
From Chemiexcitation: Mammalian Photochemistry in the Dark<sup>†</sup> (2023) · cites this paper as [239]
The Results (§3.1; page unavailable) concern dopamine and noradrenergic neuron loss in MPTP-treated monkeys. Searches of our copy for MC1R, red hair, melanoma, and a 7-fold melanoma risk found no passage addressing either part of the claim. (LLM, conf=0.76)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works
Frequency Dependence of Signal Power and Spatial Reach of the Local Field Potential
Leski, S., Lindén, H., Tetzlaff, T., Pettersen, K. H., & Einevoll, G. T. (2013) · PubMed Central · doi:10.18154/rwth-conv-084442 · Cited by 3,662 · see citing works
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529 · see citing works
Burns, R. S., Chiueh, C. C., Markey, S. P., Ebert, M. H., Jacobowitz, D. M., & Kopin, I. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.14.4546 · Cited by 2,149 · see citing works
Nucleus locus ceruleus: new evidence of anatomical and physiological specificity
Foote, S. L., Bloom, F. E., & Aston-Jones, G. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.3.844 · Cited by 1,901 · see citing works
Ehringer, H., & Hornykiewicz, O. (1960) · Journal of Molecular Medicine · doi:10.1007/bf01485901 · Cited by 1,875 · see citing works
The sympathetic control of blood pressure
Guyenet, P. G. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1902 · Cited by 1,814 · see citing works
(1991) · Medical Entomology and Zoology · Cited by 1,512 · see citing works
Swanson, L. W., & Hartman, B. K. (1975) · The Journal of Comparative Neurology · doi:10.1002/cne.901630406 · Cited by 1,479 · see citing works
Parent, A., & Hazrati, L. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00008-d · Cited by 1,351 · see citing works
Rémy, P., Doder, M., Lees, A. J., Turjanski, N., & Brooks, D. J. (2005) · Brain · doi:10.1093/brain/awh445 · Cited by 1,046 · see citing works
Aston-Jones, G., & Bloom, F. (1981) · Journal of Neuroscience · doi:10.1523/jneurosci.01-08-00887.1981 · Cited by 1,033 · see citing works
Zarow, C., Lyness, S. A., Mortimer, J. A., & Chui, H. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.337 · Cited by 1,003 · see citing works
Langston, J. W., Forno, L. S., Rebert, C. S., & Irwin, I. (1984) · Brain Research · doi:10.1016/0006-8993(84)90777-7 · Cited by 922 · see citing works
Ascending projections of the locus coeruleus in the rat. II. Autoradiographic study
Jones, B. E., & Moore, R. Y. (1977) · Brain Research · doi:10.1016/0006-8993(77)90378-x · Cited by 865 · see citing works
Gonon, F. G. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90307-7 · Cited by 676 · see citing works
Design-based stereology in neuroscience
Schmitz, C., & Hof, P. R. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.050 · Cited by 676 · see citing works
Adaptive gain and the role of the locus coeruleus–norepinephrine system in optimal performance
Aston‐Jones, G., & Cohen, J. D. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20723 · Cited by 630 · see citing works
Phillipson, O. T. (1979) · The Journal of Comparative Neurology · doi:10.1002/cne.901870108 · Cited by 553 · see citing works
Feinstein, R., Kanety, H., Papa, M. Z., Lunenfeld, B., & Karasik, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74276-8 · Cited by 550 · see citing works
Optimizing sampling efficiency of stereological studies in biology: or ‘Do more less well!‘
Gundersen, H. J. G., & Østerby, R. (1981) · Journal of Microscopy · doi:10.1111/j.1365-2818.1981.tb01199.x · Cited by 536 · see citing works
Fornai, F., Schlüter, O. M., Lenzi, P., Gesi, M., Ruffoli, R., Ferrucci, M., Lazzeri, G., Busceti, C. L., Pontarelli, F., Battaglia, G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409713102 · Cited by 526 · see citing works
THE BRAIN-STEM LESIONS IN PARKINSONISM
GREENFIELD, J. G., & Bosanquet, F. D. (1953) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.16.4.213 · Cited by 494 · see citing works
Locus coeruleus and regulation of behavioral flexibility and attention
(2000) · Progress in Brain Research · doi:10.1016/s0079-6123(00)26013-5 · Cited by 400 · see citing works
Afferents of the ventral tegmental area in the rat-anatomical substratum for integrative functions
Geisler, S., & Zahm, D. S. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20668 · Cited by 379 · see citing works
Locus ceruleus lesions and eosinophilic inclusions in MPTP‐treated monkeys
Forno, L. S., Langston, J. W., DeLanney, L. E., Irwin, I., & Ricaurte, G. A. (1986) · Annals of Neurology · doi:10.1002/ana.410200403 · Cited by 351 · see citing works
The adrenergic innervation of the rat thalamus as revealed by the glyoxylic acid fluorescence method
Lindvall, O., Björklund, A., Nobin, A., & Stenevi, U. (1974) · The Journal of Comparative Neurology · doi:10.1002/cne.901540307 · Cited by 318 · see citing works
Canteras, N. S., Shammah‐Lagnado, S. J., Silva, B. A., & Ricardo, J. A. (1990) · Brain Research · doi:10.1016/0006-8993(90)91087-w · Cited by 306 · see citing works
Snyder, S. H., & D’Amato, R. J. (1986) · Neurology · doi:10.1212/wnl.36.2.250 · Cited by 295 · see citing works
Connections of the subthalamic nucleus in the monkey
Carpenter, M. B., Carleton, S. C., Keller, J. T., & Conte, P. (1981) · Brain Research · doi:10.1016/0006-8993(81)91113-6 · Cited by 274 · see citing works
Chan‐Palay, V., & Asan, E. (1989) · The Journal of Comparative Neurology · doi:10.1002/cne.902870307 · Cited by 237 · see citing works
Tredici, K. D., & Braak, H. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301817 · Cited by 237 · see citing works
Jones, B. E., Halaris, A. E., McIlhany, M. P., & Moore, R. Y. (1977) · Brain Research · doi:10.1016/0006-8993(77)90377-8 · Cited by 231 · see citing works
Pifl, C., Schingnitz, G., & Hornykiewicz, O. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90080-8 · Cited by 225 · see citing works
Locus Coeruleus, A5 and A7 Noradrenergic Cell Groups
Aston‐Jones, G. (2004) · Elsevier eBooks · doi:10.1016/b978-012547638-6/50012-2 · Cited by 216 · see citing works
Mavridis, M., Degryse, A. ‐., Lategan, A. J., Marien, M. R., & Colpaert, F. C. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90345-o · Cited by 211 · see citing works
Ehringer, H., & Hornykiewicz, O. (1998) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(98)00012-1 · Cited by 204 · see citing works
Kawasaki, Y., Kumamoto, E., Furue, H., & Yoshimura, M. (2003) · Anesthesiology · doi:10.1097/00000542-200303000-00016 · Cited by 199 · see citing works
Parkinson's disease and dementia
Cash, R., Dennis, T., L'Heureux, R., Raisman‐Vozari, R., Javoy-Agid, F., & Scatton, B. (1987) · Neurology · doi:10.1212/wnl.37.1.42 · Cited by 196 · see citing works
Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area
Grenhoff, J., & Svensson, T. H. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90351-h · Cited by 190 · see citing works
Hilaire, G., Viemari, J., Coulon, P., Simonneau, M., & Bévengut, M. (2004) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2004.04.016 · Cited by 179 · see citing works
Rinaman, L. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-31-10084.2003 · Cited by 166 · see citing works
The locus ceruleus and dementia in Parkinson's disease
Zweig, R. M., Cardillo, J. E., Cohen, M. L., Giere, S., & Hedreen, J. C. (1993) · Neurology · doi:10.1212/wnl.43.5.986 · Cited by 161 · see citing works
Noradrenaline provides long‐term protection to dopaminergic neurons by reducing oxidative stress
Troadec, J., Marien, M. R., Darios, F. D., Hartmann, A., Ruberg, M., Colpaert, F. C., & Michel, P. P. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00556.x · Cited by 157 · see citing works
Mitchell, I., Cross, A. J., Sambrook, M. A., & Crossman, A. R. (1985) · Neuroscience Letters · doi:10.1016/0304-3940(85)90424-0 · Cited by 157 · see citing works
Mejias-Aponte, C., Drouin, C., & Aston-Jones, G. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4632-08.2009 · Cited by 137 · see citing works
Dumont, É. C., & Williams, J. T. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0425-04.2004 · Cited by 137 · see citing works
Russo, C. D., Boullerne, A. I., Gavrilyuk, V., & Feinstein, D. L. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-9 · Cited by 137 · see citing works
Marsh, L., Biglan, K., Gerstenhaber, M., & Williams, J. R. (2008) · Movement Disorders · doi:10.1002/mds.22307 · Cited by 135 · see citing works
Jardanhazi‐Kurutz, D., Kummer, M. P., Terwel, D., Vogel, K., Dyrks, T., Thiele, A., & Heneka, M. T. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.02.001 · Cited by 133 · see citing works
Amphetamine selectively blocks inhibitory glutamate transmission in dopamine neurons
Paladini, C. A., Fiorillo, C. D., Morikawa, H., & Williams, J. T. (2001) · Nature Neuroscience · doi:10.1038/85124 · Cited by 121 · see citing works
Simon, H., Moal, M. L., Stinus, L., & Calas, A. (1979) · Journal of Neural Transmission · doi:10.1007/bf01252703 · Cited by 119 · see citing works
Masilamoni, G. J., Bogenpohl, J. W., Alagille, D., Delevich, K. M., Tamagnan, G. D., Votaw, J. R., Wichmann, T., & Smith, Y. (2011) · Brain · doi:10.1093/brain/awr137 · Cited by 118 · see citing works
Self-citationAlpha1‐adrenergic Effects on Dopamine Neurons Recorded Intracellularly in the Rat Midbrain Slice
Grenhoff, J., North, R. A., & Johnson, S. W. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00692.x · Cited by 116 · see citing works
Halliday, G. M., Tredici, K. D., & Braak, H. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_16 · Cited by 113 · see citing works
Emerging dysfunctions consequent to combined monoaminergic depletions in parkinsonism
Delaville, C., Chetrit, J., Abdallah, K., Morin, S., Cardoit, L., Deurwaerdère, P. D., & Benazzouz, A. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.10.023 · Cited by 109 · see citing works
Hantraye, P., Varastet, M., Peschanski, M., RICHE, D., Césaro, P., Jc, W., & Mazière, M. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90295-q · Cited by 107 · see citing works
Srinivasan, J., & Schmidt, W. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02684.x · Cited by 103 · see citing works
Prazosin: Effect on psychomotor-stimulant cues and locomotor activity in mice
Snoddy, A. M., & Tessel, R. E. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90156-6 · Cited by 99 · see citing works
Bing, G., Zhang, Y., Watanabe, Y., McEwen, B. S., & Stone, E. A. (1994) · Brain Research · doi:10.1016/0006-8993(94)90534-7 · Cited by 96 · see citing works
Paolo, T. D., Bédard, P. J., Daigle, M., & Boucher, R. (1986) · Brain Research · doi:10.1016/0006-8993(86)90782-1 · Cited by 93 · see citing works
Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice
Marien, M. R., Briley, M., & Colpaert, F. C. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90489-5 · Cited by 92 · see citing works
Liprando, L. A., Miner, L. H., Blakely, R., Lewis, D. A., & Sesack, S. R. (2004) · Synapse · doi:10.1002/syn.20023 · Cited by 84 · see citing works
Alterations in the locus coeruleus in dementias of Alzheimer's and Parkinson's disease
Chan‐Palay, V. (1991) · Progress in brain research · doi:10.1016/s0079-6123(08)63839-x · Cited by 84 · see citing works
Intrinsic Regulation of Brain Inflammatory Responses
Galea, E., Heneka, M. T., Russo, C. D., & Feinstein, D. L. (2003) · Cellular and Molecular Neurobiology · doi:10.1023/a:1025084415833 · Cited by 74 · see citing works
Reduced MPTP toxicity in noradrenaline transporter knockout mice
Rommelfanger, K. S., Weinshenker, D., & Miller, G. W. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02785.x · Cited by 73 · see citing works
Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice
Fornai, F., Bassi, L., Torracca, M. T., Scalori, V., & Corsini, G. U. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00313-a · Cited by 71 · see citing works
Chopin, P., Colpaert, F. C., & Marien, M. R. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38022-x · Cited by 67 · see citing works
Belujon, P., Bézard, E., Taupignon, A., Bioulac, B. H., & Benazzouz, A. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2583-07.2007 · Cited by 66 · see citing works
Excitation of neuronal function in rabbit caudal ventrolateral medulla elevates plasma vasopressin
Blessing, W. W., & Willoughby, J. O. (1985) · Neuroscience Letters · doi:10.1016/0304-3940(85)90162-4 · Cited by 66 · see citing works
Traver, S., Salthun-Lassalle, B., Marien, M. R., Hirsch, É. C., Colpaert, F. C., & Michel, P. P. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.007864 · Cited by 65 · see citing works
Clonidine regularizes substantia nigra dopamine cell firing
Grenhoff, J., & Svensson, T. H. (1988) · Life Sciences · doi:10.1016/0024-3205(88)90500-0 · Cited by 61 · see citing works
Vogt, B., Hof, P., Friedman, D. P., Sikes, R., & Vogt, L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0178-0 · Cited by 61 · see citing works
Selective noradrenergic vulnerability in alpha-synuclein transgenic mice
Sotiriou, E., Vassilatis, D. K., Vila, M., & Stefanis, L. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.11.010 · Cited by 59 · see citing works
Srinivasan, J., & Schmidt, W. (2003) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.08.016 · Cited by 55 · see citing works
Inhibition of Perforant Path Input to the CA1 Region by Serotonin and Noradrenaline
Otmakhova, N. A., Lewey, J., Asrican, B., & Lisman, J. E. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00217.2005 · Cited by 49 · see citing works
Core and paracores; some new chemoarchitectural entities in the mammalian neuraxis.
Nieuwenhuys, R., Veening, J. G., & van Domburg, P. (1989) · PubMed · Cited by 43 · see citing works
Bédard, M., Massioui, F. E., Malapani, C., Dubois, B., Pillon, B., Renault, B., & Agid, Y. (1998) · PubMed · Cited by 42 · see citing works
18F-FECNT: Validation as PET dopamine transporter ligand in parkinsonism
Masilamoni, G. J., Votaw, J. R., Howell, L. L., Villalba, R. M., Goodman, M. M., Voll, R. J., Stehouwer, J. S., Wichmann, T., & Smith, Y. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.08.024 · Cited by 42 · see citing works
Self-citationPintor, L., Baillés, E., Valldeoriola, F., Tolosa, E. S., Martı́, M. J., & de Pablo, J. (2005) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2005.07.005 · Cited by 39 · see citing works
Mourlevat, S., Troadec, J., Ruberg, M., & Michel, P. P. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.3.578 · Cited by 35 · see citing works
Effect of the α2 adrenoreceptor antagonist, idazoxan, on motor disabilities in MPTP-treated monkey
Bézard, E., Brefel‐Courbon, C., Tison, F., Peyro-Saint-Paul, H., Ladure, P., Rascol, O., & Gross, C. E. (1999) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(99)00067-6 · Cited by 34 · see citing works
Arcos, D., Sierra, A., Núñez, A., Flores, G., Aceves, J., & Arias‐Montaño, J. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00315-0 · Cited by 34 · see citing works
(2011) · Wiley eBooks · doi:10.1002/9781444397970 · Cited by 32 · see citing works
Adrenergic Receptors: Classification, ligand binding and molecular properties
Wikberg, J. E. S. (1982) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1982.tb00405.x · Cited by 30 · see citing works
Ginsberg, S. D., Hof, P. R., Young, W. G., & Morrison, J. H. (1993) · The Journal of Comparative Neurology · doi:10.1002/cne.903270410 · Cited by 29 · see citing works
Gibb, W. R. G., Terruli, M., Lees, A. J., Jenner, P. G., & MARSDEN, C. D. (1989) · Movement Disorders · doi:10.1002/mds.870040109 · Cited by 27 · see citing works
Cathala, L., Guyon, A., Eugène, D., & Paupardin‐Tritsch, D. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00542-0 · Cited by 27 · see citing works
Coenen, V. A., Gielen, F. L. H., Castro-Prado, F., Rahman, A. A., & Honey, C. R. (2008) · Acta Neurochirurgica · doi:10.1007/s00701-008-1619-5 · Cited by 25 · see citing works
Ferry, B., Parrot, S., Marien, M. R., Lazarus, C., Cassel, J., & McGaugh, J. L. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.09.010 · Cited by 25 · see citing works
Herrero, M. T., Hirsch, É. C., Javoy-Agid, F., Obeso, J. A., & Agid, Y. (1993) · Brain Research · doi:10.1016/0006-8993(93)90088-5 · Cited by 21 · see citing works
Noradrenaline loss selectivity exacerbates nigrostriatal toxicity in different species of rodents.
Fornai, F., Bassi, L., Bonaccorsi, I., Giorgi, F. S., & Corsini, G. U. (1997) · PubMed · Cited by 19 · see citing works
Antibodies raised against different oligopeptide segments of human dopamine-β-hydroxylase
Nagatsu, I., Kobayashi, K., Fujii, T., Komori, K., Sekiguchi, K., Titani, K., Fujita, K., & Nagatsu, T. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90023-3 · Cited by 18 · see citing works
Bean, A., & Roth, R. H. (1991) · Brain Research · doi:10.1016/0006-8993(91)90613-z · Cited by 15 · see citing works
Flagged first, then by citations
2 of the 96 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Gaspar P 1994 Anatomy of the Noradrenergic Pathways in the Primate Brain Alteration in Parkinson’s Disease CRC Press Boca Raton 73 88
Cited by
Sorted by citations
Benarroch, E. E. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2649-1 · Cited by 218 · see citing works
Freezing of gait: understanding the complexity of an enigmatic phenomenon
Weiß, D., Schöllmann, A., Fox, M., Bohnen, N. I., Factor, S. A., Nieuwboer, A., Hallett, M., & Lewis, S. J. G. (2019) · Brain · doi:10.1093/brain/awz314 · Cited by 175 · see citing works
The Noradrenergic System in Parkinson’s Disease
Paredes-Rodriguez, E., Vegas‐Suárez, S., Morera‐Herreras, T., Deurwaerdère, P. D., & Miguélez, C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00435 · Cited by 165 · see citing works
Li, Y., Wang, C., Wang, J., Zhou, Y., Ye, F., Zhang, Y., Cheng, X., Huang, Z., Liu, K., Fei, G., et al. (2019) · Movement Disorders · doi:10.1002/mds.27682 · Cited by 81 · see citing works
Masilamoni, G. J., & Smith, Y. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1774-z · Cited by 79 · see citing works
Self-citationFerroptosis: A potential therapeutic target for neurodegenerative diseases
Vitalakumar, D., Sharma, A., & Flora, S. J. S. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22830 · Cited by 73 · see citing works
Nonhuman Primate Models of Neurodegenerative Disorders
Emborg, M. E. (2017) · ILAR Journal · doi:10.1093/ilar/ilx021 · Cited by 64 · see citing works
Nexus between mitochondrial function, iron, copper and glutathione in Parkinson's disease
Liddell, J. R., & White, A. R. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.05.016 · Cited by 62 · see citing works
Joers, V., Masilamoni, G., Kempf, D., Weiss, A. R., Rotterman, T. M., Murray, B., Yalcin-Cakmakli, G., Voll, R. J., Goodman, M. M., Howell, L., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105027 · Cited by 56 · see citing works
Self-citationBos, M. J., Bühre, W., Temel, Y., Joosten, E. A. J., Absalom, A. R., & Janssen, M. L. F. (2020) · Journal of Neurosurgical Anesthesiology · doi:10.1097/ana.0000000000000673 · Cited by 52 · see citing works
Choudhury, G. R., & Daadi, M. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202770 · Cited by 51 · see citing works
Chemiexcitation and Its Implications for Disease
Brash, D. E., Gonçalves, L. C. P., & Bechara, E. J. H. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.04.004 · Cited by 36 · see citing works
Li, Y. H., Jiao, Q., Du, X., Bi, M., Han, S., Jiao, L., & Jiang, H. F. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00241 · Cited by 36 · see citing works
Spay, C., Albares, M., Lio, G., Thobois, S., Broussolle, E., Lau, B., Ballanger, B., & Boulinguez, P. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14447 · Cited by 22 · see citing works
Chemiexcitation: Mammalian Photochemistry in the Dark<sup>†</sup>
Brash, D. E., & Goncalves, L. C. P. (2023) · Photochemistry and Photobiology · doi:10.1111/php.13781 · Cited by 16 · see citing works
Cortical Serotonergic and Catecholaminergic Denervation in MPTP-Treated Parkinsonian Monkeys
Masilamoni, G. J., Weinkle, A. P., Papa, S. M., & Smith, Y. (2021) · Cerebral Cortex · doi:10.1093/cercor/bhab313 · Cited by 17 · see citing works
Self-citationDuperrier, S., Bortolozzi, A. A., & Sgambato, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158586 · Cited by 15 · see citing works
Salvatore, M. F., Soto, I., Alphonso, H. M., Cunningham, R. L., James, R., & Nejtek, V. A. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202449 · Cited by 15 · see citing works
Leveraging animal models to understand non-motor symptoms of Parkinson's disease
Wichmann, T., Nelson, A., Torres, E. R. S., Svenningsson, P., & Marongiu, R. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106848 · Cited by 14 · see citing works
Zhou, Y., Li, M., Zhu, D., Jiang, T., Gao, Q., Tang, X.-H., Zhang, S.-G., Lu, J., & Zhang, Y. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.04.005 · Cited by 11 · see citing works
Neurotransmitter and receptor systems in the subthalamic nucleus
Emmi, A., Campagnolo, M., Stocco, E., Carecchio, M., Macchi, V., Antonini, A., De, R., & Porzionato, A. (2023) · Brain Structure and Function · doi:10.1007/s00429-023-02678-z · Cited by 8 · see citing works
Huang, P.-H., Pan, Y.-S., Chen, S.-Y., & Lin, S.-H. (2024) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2024.04.002 · Cited by 8 · see citing works
Barut, J., Rafa–Zabłocka, K., Jurga, A. M., Bagińska, M., Nalepa, I., Parlato, R., & Kreiner, G. (2022) · Neurochemistry International · doi:10.1016/j.neuint.2022.105302 · Cited by 5 · see citing works
Fang, Y., Zhou, C., Zhu, B., Liu, J., Liu, S., Guan, X., Guo, T., Xu, X., Zhang, M., Tian, J., et al. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70214 · Cited by 6 · see citing works
MPTP Neurotoxicity: Actions, Mechanisms, and Animal Modeling of Parkinson’s Disease
Ferrucci, M., & Fornai, F. (2021) · Springer eBooks · doi:10.1007/978-3-030-71519-9_239-1 · Cited by 4 · see citing works
Oñate‐Ponce, A., Muñoz, C. M. , Catenaccio, A., Court, F. A., & Henny, P. (2024) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2024.110226 · Cited by 3 · see citing works
Ren, Z., Sun, H., Xiu, S., Yang, N., Liu, Y., & Chan, P. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175944 · Cited by 2 · see citing works
Ehsanifar, M., & Montazeri, Z. (2022) · Journal of Biomedical Research & Environmental Sciences · doi:10.37871/jbres1408 · Cited by 2 · see citing works
MPTP Neurotoxicity: Actions, Mechanisms, and Animal Modeling of Parkinson’s Disease
Ferrucci, M., & Fornai, F. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_239 · Cited by 1 · see citing works
Joers, V. L., Masilamoni, G. J., Kempf, D., Weiss, A. R., Rotterman, T. M., Murray, B., Çakmaklı, G. Y., Voll, R. J., Goodman, M. M., Howell, L. L., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.30.925883 · Cited by 1 · see citing works
Self-citationMolecular imaging beyond dopamine and serotonin in familial and idiopathic Parkinson’s disease
Wilson, H., Terry, A., & Politis, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821651-4.00002-6
Bertrand, M., Ciles, J. H. D., Chabardès, S., de Leiris, N., Baudin, B., Bastin, J., & Piallat, B. (2025) · bioRxiv · doi:10.1101/2024.01.22.576571
Sleep firing rate homeostasis is disrupted in mild parkinsonism
Nandakumar, B., Verma, A. K., Yu, Y., Marshall, E., DeNicola, A. L., Wang, J., MacKinnon, C. D., Howell, M. J., Vitek, J. L., & Johnson, L. A. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-025-01256-w
Carrillo, M., Hernández-Pinedo, N., Zaldívar-Díez, J., Pérez-Santos, I., Obeso, J. A., Cavada, C., & Blesa, J. (2026) · Movement Disorders · doi:10.1002/mds.70209
Fesenko, Z. S., Volnova, A. B., Efimova, E. V., Sotnikova, T. D., & Gainetdinov, R. R. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083656
Anesthetic considerations for DBS in children
Alotaibi, F., Anbar, H., & AlDakheel, A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-23540-5.00006-0
- Authors
- Masilamoni, G. J., Groover, O., & Smith, Y.
- Affiliations
- Emory University (US)
- Corresponding author
- Smith, Yoland
- Venue
- Neurobiology of Disease
- Publisher
- Elsevier BV
- Published
- 2017-04
- Volume
- 100
- Pages
- 9-18
- ISSN
- 0969-9961 (ISSN-L)
- PMC
- PMC5511687
- OpenAlex
- W2561957799
- Cited by
- 37
- References
- 96
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 6 · 2021: 3 · 2020: 5 · 2019: 2 · 2018: 5 · 2017: 4
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurobiology of Disease (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- NIH/ORIP (P51-OD011132)
- National Parkinson Foundation
- NIH/NINDS (P50-NS071669)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Neurology › Neurological disorders and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- noradrenergic innervation, ventral midbrain, subthalamic nucleus, Parkinson's disease, MPTP, locus coeruleus, ventral tegmental area, substantia nigra pars compacta, retrorubral field, dopamine beta-hydroxylase, axodendritic synapses, rhesus monkeys, neurodegeneration
- MeSH terms
- Animals, Dendrites, Disease Models, Animal, Macaca mulatta, Male, Mesencephalon, Substantia Nigra, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, Ventral Tegmental Area, MPTP Poisoning, Subthalamic Nucleus, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review